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genome. However, it remains unclear how structure relates to function and, in this work, we 23 aim at bridging both by assembling a dataset that combines the activity of regulatory 24 elements (e.g. enhancers and promoters), expression of genes and genetic variations of 317 25 individuals and across two cell types. We show that the regulatory activity is structured 26 within 12,583 Cis Regulatory Domains (CRDs) that are cell type specific and highly reflective 27 of the local (i.e. Topologically Associating Domains) and global (i.e. A/B nuclear 28 compartments) nuclear organization of the chromatin. These CRDs essentially delimit the 29 sets of active regulatory elements involved in the transcription of most genes, thereby 30 capturing complex regulatory networks in which the effects of regulatory variants are 31 propagated and combined to finally mediate expression Quantitative Trait Loci. Overall, our 32 analysis reveals the complexity and specificity of cis and trans regulatory networks and their 33 perturbation by genetic variation. 34 the tools to achieve this task. This has already given key insights into the molecular 48 mechanisms underlying eQTLs function and the consensus picture that now emerges 49 involves the binding perturbation of transcription factors which result in variable activity of 50 the corresponding regulatory elements (Spitz and Furlong, 2012) . These effects then 51 propagate to distal regulatory elements and genes through chromatin interactions ( To further characterize gene regulatory networks and their perturbation by genetic variants, 58 we extended our previous work (Waszak et al., 2015) and assayed a combination of three 59 well-studied histone modifications (H3K27ac, H3K4me1 and H3K4me3), which are known to 60 reliably capture enhancer and promoter activities, in 317 lymphoblastoid cell lines (LCLs) 61 and 78 primary fibroblasts derived from unrelated European individuals (methods 1-2). We and found a strong signal of correlation (pi1=18.7%; methods 7) that rapidly decays with 93 distance, slightly varies across ChIP-seq assay pairs, is driven by the most variable chromatin 94 peaks (supplementary figures 6A-C) and importantly forms well-delimited domains that we 95 call Cis Regulatory Domains (CRDs; figure 1A-C). We then looked at the fibroblast data to 96 infer the cell type specificity of the significant correlations and found that long range 97 correlations (e.g. > 100kb) are less shared between cell types than short range ones (e.g. < 98 131
CRDs delimit functionally active and variable TAD subdomains 132
Given the high concordance between Hi-C contacts and correlation data, we compared CRDs 133 to a collection of TADs derived from a deep LCL Hi-C experiment that constitutes the most 134 detailed definition of TADs so far (methods 3). CRDs are substantially smaller than TADs 135 (32kb versus 185kb; figure 1F ) even though they can reach the same size in some cases (up 136 to 1Mb). When comparing the genomic regions defined by both CRDs and TADs, we find 137 that 90% of the TADs overlap at least one CRD, 57% at least two and that CRDs tend to be 138 fully encompassed within TAD boundaries (supplementary figures 8A-B) . In addition, we 139 also observed a higher density of CTCF binding sites at CRD boundaries similar to what is 140 known for TADs (supplementary figure 8C) (Rao et al., 2014) . All this constitutes 141 accumulating evidences that CRDs actually correspond to TAD subdomains. 142
143
We then aimed at explaining why some of these TAD sub-domains correspond to CRDs while 144 some others do not. To do so, we categorized the chromatin peaks into four categories 145 depending on their location relative to both TADs and CRDs. First, this showed that 146 chromatin peaks within CRDs are very likely to also fall within TADs (OR=1.75, fisher p-value 147 < 1e-300); confirming the similarity between chromatin activity and structure. When 148 focusing exclusively on TAD specific chromatin peaks and looking at their activity across all 149 individuals, we find that those that are also members of CRDs exhibit much higher mean 150 activity and variability than those that are not ( figure 1G; supplementary figure 8D) . 151
Together, this suggests that TADs mix together inactive (potential) and active (realized) 152 subdomains and we propose that active ones correspond to CRDs. 153 154 3. Inter-chromosomal correlation between CRDs reflects nuclear organization of DNA 155 By using fluorescence microscopy or Hi-C assays, multiple studies have characterized a high 156 level organization of the chromatin; within chromosome territories (Meaburn and Misteli, 157 2007), A/B nuclear compartments (Lieberman-Aiden et al., 2009) and sub-compartments 158 (Rao et al., 2014) . Here, we used population variability of chromatin activity as perturbation 159 to uncover the interactions underlying the global chromatin architecture. Specifically, we 160 measured inter-individual correlations for all pairs of chromatin peaks located on distinct 161 chromosomes (n=~3.4e10 tests) and found a substantial signal of association (pi1=8.1%; 162 estimated by data sub-sampling). Given the difficulty to properly control for FDR in this 163 massive multiple-testing setting, we first examined the data by considering as significant any 164 pair of chromatin peaks with an association P-value below 1e-6. By doing so, we observed 165 that some chromosomes preferentially associate with some others ( figure 2A) ; notably 166 chromosomes 16, 17, 19, 20 and 22 in line with the observation that these chromosomes 167 tend to locate at the center of the nucleus thereby increasing their chance to interact with 168 other chromosomes (Kaufmann et al., 2015) . We also found that the per-chromosome 169 association frequency (i.e. the fraction of tests per-chromosome with a p-value < 1e-6) 170
correlates well with gene density (figure 2E) suggesting that gene rich chromosomes 171 participate more to inter-chromosomal chromatin interactions (Kalhor et al., 2011) . power to analyze the genetic effects on CRDs . We therefore searched for Quantitative Trait 244 Loci (QTLs) for both genes and CRDs. Concerning CRDs, we did not only quantify their 245 activity as described before but also their structure by quantifying for each individual 246 whether its data contributed positively or negatively to the overall correlation structure 247 (methods 8-9). To summarize, we tested three molecular phenotypes for association with 248 nearby genetic variants (methods 4), thereby resulting in three different kinds of QTL 249 discoveries: at the gene expression level (eQTL), at the CRD activity level (aCRD-QTL) and at 250 the CRD structure level (sCRD-QTL). In total, we discovered 6,157 aCRD-QTLs (pi1=68.5%), 251 7,658 eQTLs (pi1=59.2%) and 110 sCRD-QTLs (pi1=11.3%; figures 4A-B; supplementary 252 figure 13A), which demonstrates that, similarly to genes, CRDs are under very strong genetic 253 control. In terms of genomic distribution, all three types of QTLs exhibit the same pattern: 254 they tend to become stronger and more frequent as we get closer to the genomic source of 255 the target phenotype (supplementary figure 13B) . However, in terms of minor allele 256 frequency (MAF) spectrum, they show some differences: sCRD-QTLs involve almost 257 exclusively genetic variants with a MAF below 20% while both eQTLs and aCRD-QTLs span 258 the full MAF range ( figure 4C) ; suggesting that the sCRD-QTLs are under intense selective 259 pressure. This is also supported by the observation that sCRD-QTLs involve more often a loss 260 of protein binding motifs compared to aCRD-QTLs and eQTLs (supplementary methods D13; 261 supplementary figure13C). To summarize, this suggests two kinds of genetic variations 262 affecting CRDs; the frequent case involving common genetic variants modulating the CRD 263 activity through perturbation of protein binding affinity and the more deleterious case 264 involving rare genetic variants that change the CRD structure by disrupting internal 265 interactions. 266 267 As a natural step forward, we then assessed the extent to which these molecular QTLs 268 overlap. In the context of our study, this task is greatly facilitated by the availability of a 269 dense genome-wide map interconnecting genes and CRDs, which, in practice, allows testing 270 for association QTLs of CRDs with relevant genes. Overall, we found extensive overlaps 271 between all types of molecular QTLs ( figure 4D ). More specifically, we first observed that 272 sCRD-QTLs are almost fully recapitulated by aCRD-QTLs (pi1=94.5%); indicating that 273 perturbations of the CRD structure also result in activity variations. We then found that 274 we tried to look at how multiple eQTLs with independent effects on a given gene actually 286 decompose into individual effects at the CRD level. We performed conditional analyses to 287 supplement our previous QTL discoveries with additional independent ones (supplementary 288 methods D14) and then compared the numbers of QTLs per gene and CRD by leveraging the 289 gene-CRD associations. We have observed that genes with multiple eQTLs associate more 290 often with (a) a single CRD having multiple aCRD-QTLs (OR=1.81) or (b) with more than 1 291 CRDs (OR=1.42) compared to genes with a single eQTL (figure 4E). This demonstrates that 292 the joint effect of multiple eQTLs on a gene results from molecular interactions at two 293 different levels: between regulatory elements within a single CRD or between distinct CRDs. 294
Then, we asked how genetic effects actually flow through genes and CRDs in order to 295 understand the causal relationships. A prerequisite of our analysis is to focus exclusively on 296 genetic variants that affect both molecular phenotypes simultaneously. To detect these, we 297 applied a Principal Component Analysis on each of the 12,204 gene-CRD associations and 298 used the individual coordinates on PC1 as quantifications for QTL mapping. In total, we 299 discovered 8,706 QTLs for gene-CRD pairs (called eCRD-QTLs; CRD-expression QTLs) and 300 estimated that pi1=81.7% of these pairs mediate genetic effects. We then used Bayesian 301
Network modeling to unravel causal relationships, an approach that has already been used 302 for causal inference between genetic variants and molecular phenotypes (Gutierrez-Arcelus 303 et al., 2013) (methods 10). In our study, this provided very high call rates in most of the 304 cases (supplementary figure 14A) ; meaning that we were able to reliably assign a causal 305 scenario for a vast majority of the 8,706 gene-CRD-QTL triplets under consideration. Overall, 306
we find a clear signal that activity changes at CRDs are causal to changes in gene expression 307 when they originate from eCRD-QTLs distal to genes while they are reactive for proximal 308 eCRD-QTLs (figure 4F). Interestingly, this signal becomes even stronger when we only 309 focused on eCRD-QTLs directly located within CRDs (supplementary figure 14B) . This led us 310 next to distinguish the functional elements that contribute to these two types of causal 311 mechanisms (i.e. causal or reactive). We found that eCRD-QTLs involving a causal role for 312
CRDs usually map in enhancers while those that involve a reactive role for CRDs map in 313 promoters (supplementary figure 14C) . Altogether, this shows that regulatory interactions 314 within CRDs mediate the long range effects of enhancer related regulatory variations on 315 gene expression while they actually reflect these perturbations in the case of promoter 316 related regulatory variations. 317
318
The availability of four collections of molecular QTLs allows further functional comparisons. 319
First, we can determine the degree to which those QTLs are shared across cell types. To do 320 so, we quantified all the LCL features (CRDs, gene-CRD pairs and genes) in the 78 fibroblast 321 samples and computed the P-values of association in fibroblasts of all significant LCL 322 discoveries. We found that between pi1=27.3% and pi1=35.4% of the QTLs for CRDs are also 323 significant in fibroblasts, a value which goes up to pi1=48% for eQTLs (supplementary figure  324   14D) . figure 14E) . 332
333
We provide here two concrete examples how the dense genome-wide map interconnecting 334 genes, CRDs and regulatory variations that we progressively assembled throughout this 335 study could empower future association studies. As a first example, we used CRDs as a 336 genome annotation to study the cumulative effect of multiple genetic variants. Specifically, 337
we used whole genome and transcriptome sequencing data from the GEUVADIS study 338 (methods 3) (Lappalainen et al., 2013) to assess if the accumulation of rare variants within a 339 CRD is associated with the expression of nearby genes (i.e. rare-eQTL effects). To this aim, a 340 'genetic burden' was defined for each CRD by counting the number of minor alleles at rare 341 variants (MAF<5%) falling into its regulatory regions and was then tested for association 342 with the expression levels of nearby genes (methods 11). This amounts to a burden test at 343 the regulatory level and showed that a non-negligible fraction of genes (pi1=10.4%) are 344 affected by rare-eQTLs ( figures 5A-B) . At 5% FDR, this resulted in 33 CRDs whose baseline 345 activity is perturbed by the accumulation of rare mutations with a level of expression of the 346 downstream gene being decreased in 64% of the cases (supplementary figure 15A) . This 347 demonstrates the potential of our approach to explore the cumulative effects of multiple 348 regulatory variations such as haplotypic effects. As a second example, we leveraged the 349 inter-chromosomal associations between CRDs to discover trans-eQTLs likely acting through (methods 12), a task that we performed in six distinct datasets compiling data from two 355 studies (the present study and EUROBATS; methods 3) and across five cell types (blood, fat, 356 LCL, skin and fibroblasts). Overall, we found association enrichments at particularly high 357 levels in the LCL datasets ( figure 5C ) potentially highlighting the cell type specificity of trans 358 effects. We then extracted the 27 hits significant at 5% FDR in the largest LCL data set 359 (EUROBATS LCL, n=765) and replicated 9 of them (p-value < 0.01 and same effect size 360 direction) in our LCL dataset (n=317; figure 5D; supplementary figure15B) . Almost none of 361 these 27 hits are replicated in other cell types supporting the notion that they are real trans 362 effects and not due to technical biases such as read mapping artifacts. By assembling all the 363 relevant associations between CRDs, genes and trans-QTLs into networks, we find that all 364 associations actually relate to two distinct variants (rs2980236 and rs7758352); the former 365 variant affecting a total of 8 genes in trans, all of them connected by a CRD hub. Then, we 366 enforced the directionality of the edges in the networks to match our mechanistic 367 hypothesis that trans-eQTLs act through chromatin interactions and assessed whether this 368 assumption is supported by the data using Bayesian networks (supplementary methods 20) . 369
Overall, the data provided extremely good support (figure 5E), thereby indicating that these 370 9 trans-eQTLs act through direct inter-chromosomal chromatin interactions. 371 372
Discussion: 373
In this study, we have analyzed genome-wide genotype, chromatin and gene expression 374 data to reveal first-and higher-order regulatory interactions in the genome by using genetic 375 variation as a perturbation. We illustrate the multiple benefits of integrating genome 376 variation of multiple molecular assays to dissect the effects of regulatory variation onto 377 gene expression at an unprecedented scale and resolution. We provide a very large set of 378 chromatin QTLs that can form the basis of many specific analyses at the gene or region level 379 in order to reveal genetic effects and interactions. We uncover the extensive interplay and 380 organization of chromatin around genes and regulatory elements that ultimately form Cis 381
Regulatory Domains (CRDs). These CRDs, while being embedded in Topologically Associating 382 Domains (TADs), have higher complexity and degree of interaction at the sub-TAD level, 383 capture local interactions with most genes and tend to be highly tissue specific. In addition, 384 they are key factors involved in the co-regulation between nearby genes. However, they can 385 also form a backbone for long-range direct interactions that result in regulation and co-386 regulation of genes at larger distances and on distinct chromosomes, revealing a level of 387 organization that was previously suspected (Williams et By drawing a dense and high resolution genome-wide map of the interplay between genetic 398 variations, regulatory elements and gene expression across two cell types, we provide a 399 unique reference resource to better interpret disease associated variants, a proof-of-400 principle that population-scale variability of molecular phenotypes is a powerful means to 401 unravel the regulatory networks underlying gene expression and that these regulatory 402 networks constitute informative priors to enhance future association studies. We also 403 introduced major methodological advances related to the processing of multi-layered 404 molecular phenotype data, notably for their integration through clustering and 405 dimensionality reduction techniques and for causal inference through Bayesian networks. 406
Future studies using such a population-scale approach should allow building on our work by 407 including larger samples to capture even weaker effects, more cell types to ultimately build 408 a cross-tissue catalog of regulatory networks, affected patients to characterize disease 409 specific regulatory signature and other molecular assays to either rationalize the 410 examination of active regulatory elements (e.g. ATAC-seq) or extend it to silencing effects 411 (e.g. ChIP-seq for H3K27me3). 
Experimental methods (supplementary methods B) 459
We cultured all cells for which no data was already available (271 LCLs and 78 fibroblasts) to 460 perform both ChIP-seq and RNA-seq. Specifically, we performed chromatin immuno-461 precipitation for three different histone modifications: H3K27ac, H3K4me1 and H3K4me3 462 and extracted total RNA. We sequenced all resulting libraries on a HiSeq2000 machine. In 463 addition, we also collected genotype data for all individuals by merging existing sequence 464 data from the 1000 Genomes project (n=145) with data we generated using Illumina Human 465 OMNI 2.5M SNP arrays (n=178). 466 467
External data (supplementary method C) 468
To analyze the data we generated, we used multiple external data sets: We mapped molecular QTL for each molecular phenotype using (i) 1,000 permutations to 504 correct for the number of genetic variants being tested in cis (+/-1 Mb from the genomic 505 feature boundaries) and (ii) the False Discovery Rate procedure implemented in the 506 R/qvalue package (Storey and Tibshirani, 2003) to correct for the number of phenotypes 507 being tested genome-wide. All these analyses were run using the QTLtools software package 508 (Delaneau et al., 2017) . 509 510
Building correlation and contact maps (supplementary methods D5-7) 511
We built correlation maps for the chromatin assays by systematically measuring inter-512 individual correlation (i.e. Pearson correlation coefficient) between any pair of chromatin 513 peaks located on the same chromosome (intra-chromosomal) or on distinct chromosomes 514 (inter-chromosomal). In multiple analyses, we measured the enrichment of small correlation 515 P-values according to various parameters of interest by using the pi1 statistics of the 516 R/qvalue package (Storey and Tibshirani, 2003) . This pi1 statistics essentially gives an 517 estimate of the number of statistical tests made under the alternative hypothesis of 518 association. In addition, we built peak-centered Hi-C contact maps by interpolating the 519 contact intensities between any pair of chromatin peaks from a deep Hi-C experiment made 520 for LCL (Rao et al., 2014) . Overall, this means that between any two chromatin peaks, we got 521 two interaction measures: (a) the correlation between activity levels of the peaks and (b) 522 the contact intensity measured by Hi-C. 523 524
Calling and quantifying CRDs (supplementary methods D8-10) 525
We called Cis Regulatory Domains (CRDs) from correlation data in two steps: (i) we 526 performed hierarchical clustering on the chromatin data to get a binary tree for each 527 chromosome that regroups the chromatin peaks depending on the correlation they exhibit 528 and (ii) we cut the resulting binary tree at the level maximizing the total correlation mass 529 captured by using three empirical criteria (i.e. overall, edge and distal correlations) which 530 gave us clusters of highly correlated chromatin peaks (i.e. the actual CRDs). Once the CRDs 531 were called, we quantified them on a per sample basis at two levels: (i) we measured their 532 overall activity by simply taking the averaged peak quantification and (ii) we measured their 533 structure by assessing the contribution of each individual onto the mean correlation within 534 the CRD. 535 536
Mapping genes and QTLs for CRDs (supplementary methods D11-12) 537
Once the CRDs quantified, we searched for associations with nearby genes and genetic 538 variants using the permutation procedure implemented in the QTLtools software package 539 (Delaneau et al., 2017) . This allowed us to efficiently correct for the fact that multiple 540 genetic variants, genes and CRDs are tested genome wide. Of note, we only searched for 541 associations within 1Mb of the CRD boundaries. For the genes, we used as genomic 542 coordinates the position of their TSSs and only considered protein coding genes or lincRNAs. 543
In some cases, we complemented this step by conditional analysis as implemented in the 544 forward-backward scan of QTLtools (Delaneau et al., 2017) . 545 546
Inferring causality (supplementary methods D15-16) 547
To infer the causal relationships between QTLs, CRDs and genes, we proceeded in two steps. 548
First, we only focused on QTLs affecting both CRDs and genes. To get those, we quantified 549 each gene-CRD pair using PCA and mapped QTLs using the coordinates on PC1 as 550 quantifications. As a byproduct, this gave us QTL-CRD-gene triplets onto which we 551 performed Bayesian Network (BN) analysis to get the posterior probabilities for the three 552 possible causal models we considered in this study: (i) the causal model with QTL > CRD > 553 gene, (ii) the reactive model QTL > gene > CRD and (iii) the independent model with QTL > 554 CRD and QTL > gene. This has been implemented using the R/bnlearn package (Scutari, 555 2010) . 556 557
CRD based burden test (supplementary methods D18) 558
We designed a burden test at the regulatory level by leveraging CRDs. This test relies on two 559 steps: (i) we measured the burden of rare mutations (minor allele at variant with a MAF < 560 5%) for each CRD and (ii) we then tested this burden with expression at relevant genes. By 561 relevant genes, we mean genes that have been previously found to be associated with the 562 CRD of interest. We performed this analysis on a dataset in which we have whole genome 563 and transcriptome data for 358 individuals (1000 Genomes Project Consortium, 2015; 564 Lappalainen et al., 2013) . 565 566
CRD driven trans-eQTL mapping (supplementary methods D19-20) 567
We built a map of gene-variant pairs located on distinct chromosome to be tested for 568 association by leveraging the inter-chromosomal CRD-CRD associations we discovered in the 569 frame of this study. We assembled together (i) gene-CRD associations (cis links), (ii) CRD-570 CRD associations (trans links) and (iii) QTL-CRD associations (cis links) which effectively 571 forms 20,489 gene-variant pairs to be tested in trans. Then, instead of performing the 572 billions of tests required by standard trans-eQTL analysis (millions of variants times 573 thousands of genes), we only focused on the 20,489 pairs this approach helped us to 574 assemble. We performed these tests in multiple data sets (e.g. EUROBATS (Buil et al., 2015) ) 575 and extracted the significant hits we obtained at 5% FDR. 576
577
Figure1: The Cis Regulatory Domains (CRDs). The squared correlations and Hi-C contact intensities (scaled between 0 and 1) between nearby chromatin peaks on chromosome 8 are shown in panel A with shades of blues and reds, respectively. Two examples containing 1,000 peaks are also shown in panels B and C together with (i) the CRDs (black triangles), (ii) the TADs (black segments) and (iii) the chromatin peak locations (grey crosses). The concordance between Hi-C and the correlation is shown in panel D: the association enrichment in the full LCL data was measured within 100 bins of increasing Hi-C contact intensities. The chromatin peak density as we move along CRDs is shown in panel E. The xaxis represents the position scaled between 0 and 1 of the chromatin peaks relative to the left and right boundaries of CRDs. The panel F compares the lengths of CRDs and TADs. And finally, the panel G gives the chromatin peak activity depending on their TAD and CRD memberships and expressed as Reads Per Millions.
Figure2:
The inter-chromosomal interactions of chromatin. The three first panels show the correlation structure between chromosomes at three different zoom levels: (A) the frequency of correlations with a P-value < 1e-6 for all pairs of chromosomes, (B) all pairs of peaks between chromosome 10 and 16 with a P-value < 1e-4 and (C) a 500x500 peaks region exhibiting high correlation; all this in the context of CRDs and local correlation between chromatin peaks. The panel D gives the association enrichments of inter-chromosomal correlations within 50 bins of increasing Hi-C contact intensities. The panel E gives the association frequency as a function of the gene density on a per-chromosome basis. The panel F shows a network representation of the 1,000 strongest inter-chromosomal associations between CRDs colored by nuclear compartment membership. The panel E shows the respective proportions of genes with one eQTL or more being associated with (i) one CRD having one aCRD-QTL (in grey), (ii) one CRD with two or more aCRD-QTLs (in blue) and (iii) two or more CRDs (in green). The panel F gives the mean probability of each causal model as a function of distance between the eCRD-QTLs and the target genes. Only data for eCRD-QTLs falling within their target CRD is shown here.
Figure5
: CRDs enhance association studies. The left panel (A) shows an example of how CRD can be used to perform a burden test of rare variants on gene expression. From top to bottom are shown (i) the pairwise correlations between peaks within the CRD, (ii) the positions of the various genomic features (peaks and gene) and (iii) the positions of the minor alleles at variants overlapping peaks for each of the 358 tested individual (sorted by increasing gene expression; low expression at the bottom). The QQplots in panel B and C show the association enrichments obtained when mapping rare-eQTLs (B; burden test) and trans-eQTLs in 6 distinct data sets (C). The panel D gives the replication P-values of the 27 significant hits found to be significant in EUROBATS LCL data. The panel E gives a network representation of the 9 replicated trans-eQTLs together with the relevant cis and trans CRDs and genes. The edge directions are set up given causal hypotheses and their robustness assessed using Bayesian networks: each weight ranges between 0 and 1; the latter meaning a direction of effect highly supported by the data.
